These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12151864)

  • 21. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Haverkate F; Thompson SG; Pyke SD; Gallimore JR; Pepys MB
    Lancet; 1997 Feb; 349(9050):462-6. PubMed ID: 9040576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
    Lindahl B; Toss H; Siegbahn A; Venge P; Wallentin L
    N Engl J Med; 2000 Oct; 343(16):1139-47. PubMed ID: 11036119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes.
    Bayes-Genis A; Conover CA; Overgaard MT; Bailey KR; Christiansen M; Holmes DR; Virmani R; Oxvig C; Schwartz RS
    N Engl J Med; 2001 Oct; 345(14):1022-9. PubMed ID: 11586954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluctuating inflammatory markers in patients with stable ischemic heart disease.
    Bogaty P; Brophy JM; Boyer L; Simard S; Joseph L; Bertrand F; Dagenais GR
    Arch Intern Med; 2005 Jan; 165(2):221-6. PubMed ID: 15668370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-Reactive Protein and secondary prevention of coronary events.
    Biasucci LM
    Clin Chim Acta; 2001 Sep; 311(1):49-52. PubMed ID: 11557253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
    Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes.
    Stefanadis C; Diamantopoulos L; Dernellis J; Economou E; Tsiamis E; Toutouzas K; Vlachopoulos C; Toutouzas P
    J Mol Cell Cardiol; 2000 Jan; 32(1):43-52. PubMed ID: 10652189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of platelet-monocyte aggregates with platelet activation, systemic inflammation, and myocardial injury in patients with non-st elevation acute coronary syndromes.
    Zhang SZ; Jin YP; Qin GM; Wang JH
    Clin Cardiol; 2007 Jan; 30(1):26-31. PubMed ID: 17262778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malondialdehyde-modified LDL as a marker of acute coronary syndromes.
    Holvoet P; Collen D; Van de Werf F
    JAMA; 1999 May; 281(18):1718-21. PubMed ID: 10328072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease.
    Arroyo-Espliguero R; Avanzas P; Quiles J; Kaski JC
    Atherosclerosis; 2009 May; 204(1):239-43. PubMed ID: 18823889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris.
    Zouridakis E; Avanzas P; Arroyo-Espliguero R; Fredericks S; Kaski JC
    Circulation; 2004 Sep; 110(13):1747-53. PubMed ID: 15381646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystatin C as a Marker of Progressing Cardiovascular Events during Coronary Heart Disease.
    Gevorgyan MM; Voronina NP; Goncharova NV; Kozaruk TV; Russkikh GS; Bogdanova LA; Korolenko TA
    Bull Exp Biol Med; 2017 Feb; 162(4):421-424. PubMed ID: 28239794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Li LF
    Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
    Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
    Eur Heart J; 1999 Oct; 20(20):1493-502. PubMed ID: 10493848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study to assess whether high sensitive C-reactive protein and carotid intima media thickness improve the predictive accuracy of exercise stress testing for coronary artery disease in perimenopausal women with typical angina.
    Sinha DP; Das M; Banerjee AK; Ahmed S; Majumdar S
    J Indian Med Assoc; 2008 Feb; 106(2):86, 88, 90 passim. PubMed ID: 18705250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-reactive protein and future cardiovascular events in statin-treated patients with angina pectoris: the extended TRUTH study.
    Nozue T; Fukui K; Yamamoto S; Kunishima T; Umezawa S; Onishi Y; Tohyama S; Takeyama Y; Morino Y; Yamauchi T; Hibi K; Sozu T; Terashima M; Michishita I;
    J Atheroscler Thromb; 2013; 20(9):717-25. PubMed ID: 23748166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.